A false-positive interpretation can occur owing to FDG uptake by local- regional lymphadenopathy reactive to the in situ breast implant (at the draining axillary and internal mammary stations) [13]. A key clinical indication for PET/CT in BIA-ALCL is cervical, thoracic, abdominal, and pelvic staging for detection of distant disease, particularly in the context of mass-forming BIA-ALCL before (potentially curative) surgical resection [13]. Breast Implant Evaluation MRI Breast Without and With IV Contrast There is no role for MRI without and with intravenous (IV) contrast for implant evaluation in asymptomatic patients with saline implants [16]. The saline from the implant is resorbed by the body without significant sequelae or secondary findings in the breast. MRI Breast Without IV Contrast There is no role for MRI without IV contrast for implant evaluation in asymptomatic patients with saline implants [16]. The saline from the implant is resorbed by the body without significant sequelae or secondary findings in the breast. US Breast There is no role for US for implant evaluation in asymptomatic patients with saline implants. The saline from the implant is resorbed by the body without significant sequelae or secondary findings in the breast. Variant 2: Adult younger than 30 years of age. Female or transfeminine. Evaluation of saline breast implants. Clinical examination equivocal for implant rupture. Initial imaging. Digital Breast Tomosynthesis Diagnostic Rupture of saline implants is usually clinically evident because the saline is resorbed by the body over a period of days and the patient experiences a change in breast size and shape [16,17]. Although DBT may be useful in patients with suspected saline implant rupture and equivocal clinical findings, DBT is typically not performed as the initial imaging study in patients <30 years of age.
Breast Implant Evaluation. A false-positive interpretation can occur owing to FDG uptake by local- regional lymphadenopathy reactive to the in situ breast implant (at the draining axillary and internal mammary stations) [13]. A key clinical indication for PET/CT in BIA-ALCL is cervical, thoracic, abdominal, and pelvic staging for detection of distant disease, particularly in the context of mass-forming BIA-ALCL before (potentially curative) surgical resection [13]. Breast Implant Evaluation MRI Breast Without and With IV Contrast There is no role for MRI without and with intravenous (IV) contrast for implant evaluation in asymptomatic patients with saline implants [16]. The saline from the implant is resorbed by the body without significant sequelae or secondary findings in the breast. MRI Breast Without IV Contrast There is no role for MRI without IV contrast for implant evaluation in asymptomatic patients with saline implants [16]. The saline from the implant is resorbed by the body without significant sequelae or secondary findings in the breast. US Breast There is no role for US for implant evaluation in asymptomatic patients with saline implants. The saline from the implant is resorbed by the body without significant sequelae or secondary findings in the breast. Variant 2: Adult younger than 30 years of age. Female or transfeminine. Evaluation of saline breast implants. Clinical examination equivocal for implant rupture. Initial imaging. Digital Breast Tomosynthesis Diagnostic Rupture of saline implants is usually clinically evident because the saline is resorbed by the body over a period of days and the patient experiences a change in breast size and shape [16,17]. Although DBT may be useful in patients with suspected saline implant rupture and equivocal clinical findings, DBT is typically not performed as the initial imaging study in patients <30 years of age.